The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Guzeva V.I.

Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Okhrim I.V.

St. Petersburg State Pediatric Medical University, St. Petersburg

Guzeva O.V.

St. Petersburg State Pediatric Medical University, St. Petersburg

Guzeva V.V.

Sankt-Peterburgskiĭ gosudarstvennyĭ pediatricheskiĭ meditsinskiĭ universitet, Sankt-Peterburg

Maksimova N.E.

St. Petersburg State Pediatric Medical University, St. Petersburg, Russia

New opportunities in the optimization of epilepsy treatment in adolescents

Authors:

Guzeva V.I., Okhrim I.V., Guzeva O.V., Guzeva V.V., Maksimova N.E.

More about the authors

Read: 920 times


To cite this article:

Guzeva VI, Okhrim IV, Guzeva OV, Guzeva VV, Maksimova NE. New opportunities in the optimization of epilepsy treatment in adolescents. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9‑2):70‑74. (In Russ.)
https://doi.org/10.17116/jnevro20171179270-74

Recommended articles:
To the Question of Metronidazole Effe­ctiveness in Rosa­cea Therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):740-743
Glucocorticoid-resistant forms of endo­crine ophthalmopathy. Russian Annals of Ophthalmology. 2024;(6):125-130
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50
Pera­mpanel treatment in IQSEC2-associated epileptic ence­phalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):143-149

References:

  1. Guzeva VI. Rukovodstvo po detskoi nevrologii. 3 izd. M.: Med inform agentstvo; 2009. (In Russ.)
  2. Karlov VA, Epilepsiya u detei i vzroslykh zhenshchin i muzhchin. M.: Meditsina; 2010. (In Russ.)
  3. Detskaya nevrologiya. Vyp. 1: klinicheskie rekomendatsii. Pod red. Guzevoi VI. M.: Izdatel’stvo OOO «MK»; 2014. (In Russ.)
  4. Studenikin VM. Epilepsy in childhood. Lechashchii vrach. 2015;5. (In Russ.)
  5. Broun TR, Kholms G.L. Epilepsiya. Klinicheskoe rukovodtvo. Per. s angl. M.: Izd-vo BINOM; 2006. (In Russ.)
  6. Epilepsiya v neiropediatrii (kollektivnaya monografiya). Pod red. Studenikina VM. M.: Dinastiya; 2011. (In Russ.)
  7. French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C, Trinka E, O’Brien TJ, Laurenza A, Patten A, Bibbian F. Perampanеl for tonic-clonic seizures in idiopathic generalized epilepsy. Neurology. 2015;85:950-957. https://doi.org/10.1212/wnl.0000000000001930
  8. De Liso P, Moavero R, Coppola G, Curatolo P, Cusmai R, De Sarro G, Franzoni E, Vigevano F, Verrotti A. Current role of perampanel in pediatric epilepsy. Ital J Pediatr. 2017;43(1):51. https://doi.org/10.1186/s13052-017-0368-6
  9. Roger J, Bureau M, Dravet Ch, Genton P. et al. Epilepticsyndromesininfancy, childhoodandadolescence. Montrouge (France). John Libbey Eurotext. 2005.
  10. Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ. 2012;344:281. https://doi.org/10.1136/bmj.e281
  11. Guzeva OV, Guzeva VI, Guzeva VV, Ochrim IV, Maksimova NE, Chokmosov MS, Shin SV. The results of an evaluation of quality of care and life in children with epilepsy. Pediatr. 2017;8:2:32-43. (In Russ.)
  12. Coppola G, Iapadre G, Operto FF, Verrotti A. New developments in the management of partial-onset epilepsy: role of brivaracetam. Drug Des Devel Ther. 2017;11:643-657. https://doi.org/10.2147/dddt.s103468
  13. Krylov VV, Guekht AB, Trifonov IS, Lebedeva AV, Kaimovsky IL, Sinkin MV, Grigorieva EV, Grishkina MN, Shyshkina LV, Kochetkova OO. Outcomes of surgical treatment of patients with pharmacoresistant epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(9):13-18. (In Russ.)
  14. Biro A, Stephani U, Tarallo T, Bast T, Schlachter K, Fleger M, Kurlemann G, Fiedler B, Leiz S, Nikanorova M, Wolff M, Müller A, Selch C, Staudt M, Kluger G, Biró A. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences. Neuropediatrics. 2015;46:110-116. https://doi.org/10.1055/s-0035-1546276
  15. Eli Heyman, Eli Lahat, Noa Levin, Orna Epstein, Lazinger M., Berkovitch M., Gandelman-Marton R. Tolerability and efficacy of perampanel in children with refractory epilepsy. Developmental Medicine & Child Neurology. 2016;59;441-444. https://doi.org/10.1111/dmcn.13362
  16. Kim HD, Chi C-S, Tayard Desudchit, Nikanorova M, Visudtibhan A, Nabangchang C, Chan DWS, Fong CY, Chang K-P, Kwan S-Y, Reyes FDL, Huang C-C, Likasitwattanakul S, Lee WT, Yung A, Dash A. Review of clinical studies of perampanel in adolescent patients. Brain Behav. 2016;6(9). https://doi.org/10.1002/brb3.505
  17. Meador KJ, Yang H, Pina-Garza JE, Laurenza A, Kumar D, Wesnes KA. Cognitive effects of adjunctive perampanel for partial-onset seizures: a randomized trial. Epilepsia. 2016;57(2):243-251. https://doi.org/10.1111/epi.13279
  18. Verrotti A, Loiacono G, Coppola G, Spalice A, Mohn A, Chiarelli F. Pharmacotherapy for children and adolescents with epilepsy. Expert Opin Pharmacother. 2011;12:175-194. https://doi.org/10.1517/14656566.2010.517194
  19. Vicente Villanueva, OneebMajid, CharcrinNabangchang, Villanueva V, Majid O, Nabangchang C, Yang H, Laurenza A, Ferry J, Hussein Z. Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures. Epilepsy Res. 2016;126-134. https://doi.org/10.1016/j.eplepsyres.2016.08.025
  20. European Medicines Agency. Fycompa summary of product characteristics, The link is active on: November 30, 2015. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf
  21. Food and Drug Administration. Fycompa Prescribing Information, 2015. The link is active on: November 30, 2015. Available at:http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202834lbl.pdf
  22. Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y. Perampanel: a novel, orally active, noncompetitive AMPA‐receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia. 2011;52:1331-1340. https://doi.org/10.1111/j.1528-1167.2011.03109.x
  23. Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, Satlin A, Squillacote D, Yang H, Zhu J, Laurenza A. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia. 2013;54(8):1481-1489. https://doi.org/10.1111/epi.12212
  24. Rosenfeld W, Conry J, Lagae L, Rozentals G, Yang H, Fain R, Williams B, Kumar D, Zhu J, Laurenza A. Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study. Eur J PaedNeurol. 2015;19:435-445. https://doi.org/10.1016/j.ejpn.2015.02.008
  25. Lagae L, Villanueva V, Meador KJ, Bagul M, Laurenza A, Kumar D, Yang H. Adjunctive perampanel in adolescents with inadequately controlled partialonset seizures: a randomized study evaluating behavior, efficacy, and safety. Epilepsia. 2016;57(7):1120-1129. https://doi.org/10.1111/epi.13417
  26. Montouris G, Yang H, Williams B, Zhou S, Laurenza A, Fain R. Efficacy and safety of perampanel in patients with drug-resistent partial seizures after conversion fromdouble-blind placebo to open-label perampanel. Epilepsy Res. 2015;114:131-140. https://doi.org/10.1016/j.eplepsyres.2015.04.011
  27. Steinhoff BJ, Hamer H, Trinka E, Schulze-Bonhage A, Bien C, Mayer T, Baumgartner C, Lerche H, Noachtar S. A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria. Epilepsy Res. 2014;108(5):986-988. https://doi.org/10.1016/j.eplepsyres.2014.03.015
  28. Patsalos PN. Drug interactions with the newer antiepileptic drugs (AEDs) — Part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Clin Pharmacokinet. 2013;52(11):927-966. https://doi.org/10.1007/s40262-013-0087-0
  29. Guzeva VI, Guzeva VI, Kasumov VR, Guzeva VV, Okhrim IV. Nevrologiya porokov golovnogo i spinnogo mozga u detei. M.: Izd-vo OOO «Sotis-Med»; SPb. 2017. (In Russ.)
  30. Mukhin KYu, Pylaeva OA. Use of perampanel in the treatment of epilepsy: a review of literature and a case report. Russkii zhurnal detskoi nevrologii. 2016;2:52-62. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.